5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb studyJ. Randolph Hecht, Albrecht Kretzschmar, Jolanda Paolini et al.|Cancer Management and Research|2015Cited by 10
Subgroup analyses from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: results of the TALLISUR trialMeinolf Karthaus, Volker Heinemann, Jorge Riera‐Knorrenschild et al.|BMC Cancer|2024Cited by 3
Abstract P4-14-01: Trastuzumab emtansine improves overall survival versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer: Final results from the phase 3 EMILIA studyVéronique Dièras, Lorenzo Gianni, David Miles et al.|Cancer Research|2016Cited by 0
Patient-reported quality of life data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil: Interim results of the TALLISUR study.Meinolf Karthaus, Albrecht Kretzschmar, Stefan Fuxius et al.|Journal of Clinical Oncology|2021Cited by 0